2026

  1. Efficacy and safety of duvakitug in patients with Crohn’s disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

  2. Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

  3. Tasty&Healthy exclusive whole food diet in asymptomatic children and young adults with biologically active Crohn’s disease: the TASTI-E randomized controlled trial

  4. Resection of the mesentery vs Kono-S anastomosis in preventing surgical recurrence for primary Crohn disease: the REMEASURE prospective, randomized, controlled trial

  5. The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results from the Phase 2 GLADIATOR Trial

  6. Proactive Drug Monitoring Versus Clinically Based Dosing for Endoscopic Healing in Pediatric Crohn’s Disease Receiving Infliximab

  7. Evaluation of oral nano-curcumin formulation effectiveness in patients with mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind clinical trial